Guideline of the Czech Hepatology Society of the ČLS JEP for diagnosis and treatment of non-alcoholic fatty liver disease

Author(s):  
Radan Brůha ◽  
Karel Dvořák ◽  
Tomáš Fejfar ◽  
Václav Šmíd ◽  
Pavel Trunečka
2013 ◽  
Vol 105 (7) ◽  
pp. 409-420 ◽  
Author(s):  
Verónica Martín-Domínguez ◽  
Rosario González-Casas ◽  
Jorge Mendoza-Jiménez-Ridruejo ◽  
Luisa García-Buey ◽  
Ricardo Moreno-Otero

2013 ◽  
Vol 13 (5) ◽  
Author(s):  
Mohammad Ebrahim Ghamar Chehreh ◽  
Mohsen Vahedi ◽  
Mohammad Amin Pourhoseingholi ◽  
Sara Ashtari ◽  
Hossein Khedmat ◽  
...  

2021 ◽  
Vol 3 (2) ◽  
pp. 71-80
Author(s):  
Margarita E. Semendyaeva

The article considers the non-alcoholic fatty liver disease as an important medical and social problem. This problem include such questions as metabolic syndrome, essential lipoproteinemia, insulinoresistance. It is possible to consider non-alcoholic steatohepatitis as predictor of liver fibrosis and chirrosis. The questions of diagnosis and treatment are discussed.


Author(s):  
O. B. Nemchaninova ◽  
E. Yu. Sklyanova ◽  
S. G. Lykova ◽  
E. N. Makhnovets ◽  
O. N. Pozdnyakova ◽  
...  

Non-alcoholic fatty liver disease (NAFLD), being a marker of significant changes in the hepatobiliary system against the background of metabolic syndrome and other endocrine pathologies, has a significant impact on the course of psoriatic disease. The presence of common mechanisms in the pathogenesis of these diseases suggests a very close relationship between them. This requires a multidisciplinary approach to studying the mechanisms of the pathogenesis of psoriasis and NAFLD, which will improve the methods of diagnosis and treatment of both diseases.


Sign in / Sign up

Export Citation Format

Share Document